Tyme Technologies, Inc. (TYME)
Tyme Technologies, Inc. (TYME)
$1.23 USD
Updated Jul 19 12:00am
Add TYME to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
TYME News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesTyme Technologies, Inc. (TYME) Company Bio
Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology indications. It is developing SM-88, a combination therapy in Phase II development for prostate cancer. The company was founded in 2011 and is based in New York, New York.
TYME Stock Chart More Charts
TYME Price/Volume Stats
| Current price | $1.23 |
| Prev. close | $1.26 |
| Day low | $1.23 |
| Day high | $1.26 |
| 50-day MA | $1.24 |
| 200-day MA | $2.20 |
| 52-week high | $4.64 |
| 52-week low | $0.92 |
| Volume | 298,900 |
| Avg. volume | 775,654 |
| Dividend yield | N/A |
| Market Cap | 137.70M |
TYME Returns
| 1-mo | 20.59% |
| 3-mo | -18.54% |
| 6-mo | -43.58% |
| 1-year | -57.73% |
| 3-year | -87.05% |
| 5-year | N/A |
| YTD | -66.67% |
| 2018 | -42.16% |
| 2017 | 70.13% |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...